US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jan 8, 2024 (3 years ago)

Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications

What was recalled

Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-2510-30

Recalling firm
Teva Pharmaceuticals USA, Inc
NDC code
0591-2510-30
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0275-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Budesonide recalls

See all